Status:
COMPLETED
Introducing Rapid Diagnostic Tests Into the Private Health Sector
Lead Sponsor:
DBL -Institute for Health Research and Development
Collaborating Sponsors:
Ministry of Health, Uganda
London School of Hygiene and Tropical Medicine
Conditions:
Fever
Malaria
Eligibility:
All Genders
1+ years
Phase:
NA
Brief Summary
Most malaria deaths occur within 48 hours of onset of symptoms, and in rural areas with poor access to health facilities, home management of malaria (HMM) can improve the timeliness of treatment and r...
Eligibility Criteria
Inclusion
- Patients with fever
- uncomplicted malaria
Exclusion
- Complicated malaria
- known allergic reactions to Lumartem
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2012
Estimated Enrollment :
2600 Patients enrolled
Trial Details
Trial ID
NCT01194557
Start Date
September 1 2010
End Date
July 1 2012
Last Update
October 12 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mukono District
Mukono, Mukono, Uganda